Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis
- PMID: 33966350
- DOI: 10.1002/ejhf.2216
Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis
Comment on
-
The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.Eur J Heart Fail. 2021 Jun;23(6):933-944. doi: 10.1002/ejhf.2201. Epub 2021 Jun 24. Eur J Heart Fail. 2021. PMID: 33928704 Free PMC article.
References
-
- Lopez B, Gonzalez A, Ravassa S, Beaumont J, Moreno MU, San José G, Querejeta R, Díez J. Circulating biomarkers of myocardial fibrosis: the need for a reappraisal. J Am Coll Cardiol 2015;65:2449-2456.
-
- Condorelli G, Jotti GS, Pagiatakis C. Fibroblast senescence as a therapeutic target of myocardial fibrosis: beyond spironolactone? J Am Coll Cardiol 2016;67:2029-2031.
-
- Lopez B, Ravassa S, Gonzalez A, Zubillaga E, Bonavila C, Bergés M, Echegaray K, Beaumont J, Moreno MU, San José G, Larman M, Querejeta R, Díez J. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure. J Am Coll Cardiol 2016;67:251-260.
-
- Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, Kühl U, Schultheiss HP. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999;99:2750-2756.
-
- Querejeta R, Varo N, Lopez B, Larman M, Artiñano E, Etayo JC, Martínez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindán JP, Díez J. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000;101:1729-1735.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical